Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study
| Autor: | Thadani, Samir R, Ristow, Bryan, Blackwell, Terri, Mehra, Reena, Stone, Katie L, Marcus, Gregory M, Varosy, Paul D, Cummings, Steven R, Cawthon, Peggy M, Osteoporotic Fractures in Men Study (MrOS) Research Group |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Aging Polysomnography Clinical Sciences Respiratory System Cardiovascular Osteoporotic Fractures in Men Study (MrOS) Research Group Electrocardiography Sleep Apnea Syndromes Risk Factors Clinical Research Atrial Fibrillation Prevalence 80 and over Humans Prospective Studies bisphosphonates Proportional Hazards Models Aged Diphosphonates Bone Density Conservation Agents Incidence sleep-disordered breathing Logistic Models Heart Disease Atrial Flutter Multivariate Analysis Osteoporosis Sleep Research |
| Zdroj: | Chest, vol 149, iss 5 |
| Popis: | BackgroundPrior studies suggested an association between bisphosphonates and atrial fibrillation/flutter (AF) in women. This relationship in men, including those with sleep-disordered breathing (SDB), remains unclear. This study evaluated the relationship between bisphosphonate use and prevalent (nocturnal) and incident (clinically relevant) AFin a population of community-dwelling older men.MethodsA total of 2,911 male participants (mean age, 76 years) of the prospective observational Osteoporotic Fractures in Men Study sleep cohort with overnight in-home polysomnography (PSG) constituted the analytic cohort. Nocturnal AF from ECGs during PSG and incident AF events were centrally adjudicated. The association of bisphosphonate use and AF was examined using multivariable-adjusted logistic regression for prevalent AF and Cox proportional hazards regression for incident AF.ResultsA total of 123 (4.2%) men were current bisphosphonate users. Prevalent nocturnal AF was present in 138 participants (4.6%). After multivariable adjustment, there was a significant association between current bisphosphonate use and prevalent AF (OR, 2.33; 95%CI, 1.13-4.79). In the subset of men with moderate to severe SDB, this association was even more pronounced (OR, 3.22; 95%CI, 1.29-8.03). However, the multivariable-adjusted relationship between bisphosphonate use and incident AF did not reach statistical significance (adjusted hazard ratio, 1.53; 95%CI, 0.96-2.45).ConclusionsThese results support an association between bisphosphonate use and prevalent nocturnal AF in community-dwelling older men. The data further suggest that those with moderate to severe SDB may be a particularly vulnerable group susceptible to bisphosphonate-related AF. Similar associations were not seen for bisphosphonate use and clinically relevant incident AF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|